Bioorganic and Medicinal Chemistry p. 1489 - 1496 (2019)
Update date:2022-08-02
Topics:
Liu, Qianqian
Li, Xia
Bao, Yong-Sheng
Lu, Jingxin
Li, Hua
Huang, Zhizhen
Liu, Feiyan
Deregulation of ceramide metabolism is a hallmark of human cancer. Ceramide analogues thereby represent a new class of anti-cancer agents. We aimed at developing effective and low toxic ceramide analogues and synthesized a new class of ceramide analogues starting from L-threonine. Several analogues exhibit potent cytotoxicity against human cancer cells in vitro with IC50 as low as 4.8 μM. These ceramide analogues decreased xIAP and Bcl-xL level and exhibited significant sensitization activity to overcome human cancer cell resistance to TRAIL, a cancer-selective agent that are being tested in human clinical trials. Furthermore, we determined that these ceramide analogues effectively suppress human cancer xenograft growth in vivo with no significant toxicity at the efficacious dose. Therefore, we have developed a simple and effective method to synthesize functional ceramide analogues using L-threonine as starting material and these analogues have the great potential to be further developed as anti-cancer agents in human cancer therapy.
View MoreWEIFANG RICHEM INTERNATIONAL LTD
Contact:86-536-2222176
Address:weifang,shandong
Kunshan Yalong Trading Co,.Ltd
Contact:86-512-57621185
Address:805-807 Room Hongqiao Mansion ,1088 West Qianjin Road, Kunshan, Jiangsu,China
website:http://www.biet.com.cn/
Contact:+86-27-8369 8488
Address:No. 6, Building 21, China Merchants Fanwang, Sixin North Road, Hanyang District, Wuhan City, Hubei Province
Contact:(86) 731 88718666
Address:Room 1222, Unit 4, Building B, Shangcheng, No.47, Kaiyuan East Road.
Chongqing Changfeng Chemical Co., Ltd.
website:http://www.changfengchem.com
Contact:+86-23-67896333
Address:30th Floor, Longhu Ziduxingzuo Building A, 1st Branch,YuSong Rd., Yubei District, Chongqing, China
Doi:10.1002/ejoc.201701502
(2018)Doi:10.1039/c3cc47426g
(2014)Doi:10.1016/j.dyepig.2014.04.004
(2014)Doi:10.1016/S0040-4020(01)85680-5
(1994)Doi:10.1021/acs.orglett.1c01103
(2021)Doi:10.1016/j.molstruc.2014.03.011
(2014)